Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease

Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes

Steven E. Nissen, Taro Tsunoda, E. Murat Tuzcu et al. · JAMA · 2003 · 1.7K citations · Full text

Medicine, Cardiology, Pharmacology +14

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

D. E. Schmechel, Ann M. Saunders, Warren J. Strittmatter et al. · Proceedings of the National Academy of Sciences · 1993 · 1.5K citations · Full text

Life Sciences, Genetics, Neuroscience +17

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Christine Stürchler-Pierrat, Dorothée Abramowski, Mairead Duke et al. · Proceedings of the National Academy of Sciences · 1997 · 1.5K citations · Full text

Life Sciences, Neuroscience, Pathology +17

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

Albert Hofman, Alewijn Ott, Monique M.B. Breteler et al. · The Lancet · 1997 · 1.4K citations

Medicine, Geriatric Medicine, Neurology +12

Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line

Babette Weksler, Eva-Anne Subileau, Nicolas Perrière et al. · The FASEB Journal · 2005 · 1.3K citations

Life Sciences, Cell Biology, Cell Adhesion +12